Bessemer Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.17M | Buy |
10,408
+1,843
| +22% | +$817K | 0.01% | 566 |
|
|
2026
Q1 | $3.83M | Buy |
8,565
+973
| +13% | +$454K | 0.01% | 573 |
|
|
2025
Q4 | $3.44M | Sell |
7,592
-867
| -10% | -$374K | 0.01% | 556 |
|
|
2025
Q3 | $3.31M | Buy |
8,459
+994
| +13% | +$415K | 0.01% | 411 |
|
|
2025
Q2 | $3.32M | Sell |
7,465
-19
| -0.3% | -$8.76K | 0.01% | 402 |
|
|
2025
Q1 | $3.63M | Buy |
7,484
+307
| +4% | +$143K | 0.01% | 393 |
|
|
2024
Q4 | $2.89M | Sell |
7,177
-7,613
| -51% | -$3.53M | ﹤0.01% | 571 |
|
|
2024
Q3 | $6.88M | Buy |
14,790
+1,949
| +15% | +$936K | 0.01% | 358 |
|
|
2024
Q2 | $6.02M | Buy |
12,841
+236
| +2% | +$102K | 0.01% | 349 |
|
|
2024
Q1 | $5.27M | Buy |
12,605
+9,193
| +269% | +$3.89M | 0.01% | 379 |
|
|
2023
Q4 | $1.39M | Sell |
3,412
-496
| -13% | -$183K | ﹤0.01% | 572 |
|
|
2023
Q3 | $1.36M | Buy |
3,908
+457
| +13% | +$160K | ﹤0.01% | 551 |
|
|
2023
Q2 | $1.22M | Buy |
3,451
+1,067
| +45% | +$360K | ﹤0.01% | 590 |
|
|
2023
Q1 | $750K | Buy |
2,384
+247
| +12% | +$74.1K | ﹤0.01% | 643 |
|
|
2022
Q4 | $617K | Sell |
2,137
-725
| -25% | -$221K | ﹤0.01% | 677 |
|
|
2022
Q3 | $830K | Buy |
2,862
+814
| +40% | +$234K | ﹤0.01% | 621 |
|
|
2022
Q2 | $578K | Buy |
2,048
+119
| +6% | +$31.9K | ﹤0.01% | 676 |
|
|
2022
Q1 | $504K | Buy |
1,929
+204
| +12% | +$48.4K | ﹤0.01% | 636 |
|
|
2021
Q4 | $379K | Buy |
1,725
+1,314
| +320% | +$256K | ﹤0.01% | 703 |
|
|
2021
Q3 | $74K | Sell |
411
-370
| -47% | -$72.2K | ﹤0.01% | 990 |
|
|
2021
Q2 | $158K | Sell |
781
-211
| -21% | -$44.1K | ﹤0.01% | 841 |
|
|
2021
Q1 | $214K | Buy |
992
+13
| +1% | +$2.85K | ﹤0.01% | 740 |
|
|
2020
Q4 | $232K | Buy |
979
+92
| +10% | +$21.1K | ﹤0.01% | 714 |
|
|
2020
Q3 | $241K | Sell |
887
-299
| -25% | -$82.5K | ﹤0.01% | 684 |
|
|
2020
Q2 | $344K | Buy |
1,186
+516
| +77% | +$140K | ﹤0.01% | 1047 |
|
|
2020
Q1 | $159K | Buy |
670
+256
| +62% | +$58.7K | ﹤0.01% | 1046 |
|
|
2019
Q4 | $91K | Sell |
414
-178
| -30% | -$36K | ﹤0.01% | 1195 |
|
|
2019
Q3 | $100K | Sell |
592
-1,507
| -72% | -$267K | ﹤0.01% | 1176 |
|
|
2019
Q2 | $385K | Sell |
2,099
-593
| -22% | -$104K | ﹤0.01% | 932 |
|
|
2019
Q1 | $496K | Buy |
2,692
+503
| +23% | +$92.9K | ﹤0.01% | 798 |
|
|
2018
Q4 | $362K | Buy |
2,189
+198
| +10% | +$34.3K | ﹤0.01% | 830 |
|
|
2018
Q3 | $384K | Buy |
1,991
+134
| +7% | +$23.9K | ﹤0.01% | 829 |
|
|
2018
Q2 | $315K | Sell |
1,857
-2
| -0.1% | -$310 | ﹤0.01% | 892 |
|
|
2018
Q1 | $303K | Buy |
1,859
+1,416
| +320% | +$231K | ﹤0.01% | 922 |
|
|
2017
Q4 | $66K | Sell |
443
-259
| -37% | -$38.3K | ﹤0.01% | 1213 |
|
|
2017
Q3 | $107K | Sell |
702
-19
| -3% | -$2.86K | ﹤0.01% | 1166 |
|
|
2017
Q2 | $93K | Sell |
721
-2,556
| -78% | -$308K | ﹤0.01% | 1193 |
|
|
2017
Q1 | $358K | Buy |
3,277
+3,261
| +20,381% | +$287K | ﹤0.01% | 958 |
|
|
2016
Q4 | $1K | Sell |
16
-96
| -86% | -$7.81K | ﹤0.01% | 1906 |
|
|
2016
Q3 | $10K | Sell |
112
-289
| -72% | -$27.3K | ﹤0.01% | 1527 |
|
|
2016
Q2 | $34K | Sell |
401
-37
| -8% | -$3.2K | ﹤0.01% | 920 |
|
|
2016
Q1 | $34K | Sell |
438
-600
| -58% | -$54.3K | ﹤0.01% | 969 |
|
|
2015
Q4 | $131K | Buy |
1,038
+116
| +13% | +$14K | ﹤0.01% | 798 |
|
|
2015
Q3 | $96K | Sell |
922
-10
| -1% | -$1.28K | ﹤0.01% | 842 |
|
|
2015
Q2 | $115K | Buy |
932
+53
| +6% | +$6.68K | ﹤0.01% | 827 |
|
|
2015
Q1 | $103K | Buy |
879
+29
| +3% | +$3.48K | ﹤0.01% | 820 |
|
|
2014
Q4 | $101K | Buy |
+850
| New | +$95.7K | ﹤0.01% | 801 |
|
|
2014
Q3 | – | Sell |
-221
| Closed | -$21K | – | 1399 |
|
|
2014
Q2 | $21K | Sell |
221
-315
| -59% | -$22.1K | ﹤0.01% | 1002 |
|
|
2014
Q1 | $39K | Buy |
536
+436
| +436% | +$34.5K | ﹤0.01% | 897 |
|
|
2013
Q4 | $8K | Sell |
100
-91
| -48% | -$6.34K | ﹤0.01% | 1115 |
|
|
2013
Q3 | $15K | Buy |
191
+141
| +282% | +$11.2K | ﹤0.01% | 993 |
|
|
2013
Q2 | $4K | Buy |
+50
| New | +$3.68K | ﹤0.01% | 1182 |
|
Other funds holding VRTX
Bessemer Group's VRTX Position: Q2 2026 in Review
Bessemer Group increased its Vertex Pharmaceuticals (VRTX) stake by 22% in Q2 2026, buying an estimated $817K and bringing the position to 10,408 shares worth $5.17M. The position accounts for 0.01% of the portfolio, ranked #566.
Bessemer Group first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.88M in Q3 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Bessemer Group held 10,408 shares of Vertex Pharmaceuticals worth $5.17M as of Q2 2026.
- Bessemer Group bought 1,843 Vertex Pharmaceuticals shares in Q2 2026, an estimated $817K.
- Vertex Pharmaceuticals made up 0.01% of Bessemer Group's portfolio in Q2 2026, its #566 holding.
- Bessemer Group first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Bessemer Group's Vertex Pharmaceuticals position peaked at $6.88M in Q3 2024.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.